Infection Due To Escherichia Coli — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for infection due to escherichia coli. 20 active patents protecting 3 drugs from 3+ originators. First major cliff: 2030. Daily refresh.

3
Approved drugs
20
Active US patents
64/100
Avg vulnerability
—
Annual revenue covered

Originators in Infection Due To Escherichia Coli

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents AbbVie 4 patents Novartis 2 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating infection due to escherichia coli. Each bar = one year. Y-axis scaled to peak year (7 patents).

2
26
1
27
1
28
7
30
2
31
6
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Teflaro
CEFTAROLINE FOSAMIL
 AbbVie 4 61 — 2030-09-21
Tobi
tobramycin
 Novartis 2 72 — 2028-09-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
8869794 Tobi method of use 75 2028-09-12
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8247400 Teflaro method of use 73 2031-02-10
8247400 Teflaro method of use 73 2031-02-10
10207066 Tobi method of use 68 2030-11-04
8357394 Amoxil formulation 65 2026-12-08
9603806 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10238606 Amoxil formulation 42 2034-02-12
9629861 Teflaro formulation 48 2030-09-21
9629861 Teflaro formulation 48 2030-09-21
9186411 Amoxil formulation 56 2030-08-11
9186411 Amoxil formulation 56 2030-08-11
9603806 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12
9498445 Amoxil method of use 62 2034-02-12

Related